Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-45906-5, published online 04 July 2019
The original version of this Article contained an error in Affiliation 4, which was incorrectly given as ‘Translational Science & Experimental Medicine, Early Cardiovascular, Renal and Metabolism, R&D BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden’. The correct affiliation is listed below:
Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
This error has now been corrected in the HTML and PDF versions of the Article as well as the Supplementary Information.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Diamanti, K., Cavalli, M., Pan, G. et al. Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes. Sci Rep 9, 18158 (2019). https://doi.org/10.1038/s41598-019-54423-4
Published:
DOI: https://doi.org/10.1038/s41598-019-54423-4
- Springer Nature Limited